Zivo Bioscience, Inc., together with its subsidiaries, develops natural bioactive ingredients derived from its proprietary algal cultures. The company focuses on licensing and selling its natural bioactive ingredients to animal, human and dietary supplement, and medical food manufacturers; and license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that allow individuals to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to Zivo Bioscience, Inc. in November 2014. Zivo Bioscience, Inc. is headquartered in Keego Harbor, Michigan.
Industry, Sector and Symbol
Industry Food & kindred products
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone248-452-9866
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees4
Next Earnings DateN/A
OptionableNot Optionable
Zivo Bioscience (OTCMKTS:ZIVO) Frequently Asked Questions
What is Zivo Bioscience's stock symbol?
Zivo Bioscience trades on the OTCMKTS under the ticker symbol "ZIVO."
Has Zivo Bioscience been receiving favorable news coverage?
Media coverage about ZIVO stock has been trending somewhat negative on Wednesday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Zivo Bioscience earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news stories about the biotechnology company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an effect on the stock's share price in the near future.
Who are some of Zivo Bioscience's key competitors?
What other stocks do shareholders of Zivo Bioscience own?
Who are Zivo Bioscience's key executives?
Zivo Bioscience's management team includes the folowing people:
- Mr. Philip M. Rice II, Chairman, Chief Accounting Officer & CFO (Age 64)
- Mr. Andrew A. Dahl, Pres & CEO (Age 65)
- Mr. Ronald C. Costephens, VP of Global Operations
- Dr. Scott M. Freeman M.D., Chief Science Officer (Age 62)
How do I buy shares of Zivo Bioscience?
Shares of ZIVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Zivo Bioscience's stock price today?
One share of ZIVO stock can currently be purchased for approximately $0.1216.
How big of a company is Zivo Bioscience?
Zivo Bioscience has a market capitalization of $21.88 million. Zivo Bioscience employs 4 workers across the globe.
What is Zivo Bioscience's official website?
How can I contact Zivo Bioscience?
Zivo Bioscience's mailing address is 2804 ORCHARD LAKE ROAD SUITE 202, KEEGO HARBOR MI, 48320. The biotechnology company can be reached via phone at 248-452-9866 or via email at [email protected]ivobioscience.com.
MarketBeat Community Rating for Zivo Bioscience (OTCMKTS ZIVO)
MarketBeat's community ratings are surveys of what our community members think about Zivo Bioscience and other stocks. Vote "Outperform" if you believe ZIVO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ZIVO will underperform the S&P 500 over the long term. You may vote once every thirty days.
